Ginkgo Bioworks Holdings
Stock Forecast, Prediction & Price Target
Ginkgo Bioworks Holdings Financial Estimates
Ginkgo Bioworks Holdings Revenue Estimates
Ginkgo Bioworks Holdings EBITDA Estimates
Ginkgo Bioworks Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $313.83M N/A | $477.70M 52.21% | $251.45M -47.36% | Avg: $246.92M Low: $193.06M High: $352.74M avg. -1.79% | Avg: $331.78M Low: $288.92M High: $396.35M avg. 34.36% | Avg: $605.9M Low: $527.62M High: $723.82M avg. 82.61% | |
Net Income
% change YoY
| $-1.83B N/A | $-2.10B -14.68% | $-892.86M 57.61% | Avg: $-431.02M Low: $-583.32M High: $-291.66M avg. 51.72% | Avg: $-282.31M Low: $-466.66M High: $-97.22M avg. 34.50% | Avg: $-447.21M Low: $-560.38M High: $-372.10M avg. -58.40% | |
EBITDA
% change YoY
| $-1.87B N/A | $-2.18B -16.12% | $-821.29M 62.33% | Avg: $-246.92M Low: $-352.74M High: $-193.06M avg. 69.93% | Avg: $-331.78M Low: $-396.35M High: $-288.92M avg. -34.36% | Avg: $-605.9M Low: $-723.82M High: $-527.62M avg. -82.61% | |
EPS
% change YoY
| -$1.14 N/A | -$1.25 -9.64% | -$18.37 -1369.60% | Avg: -$0.2 Low: -$0.3 High: -$0.15 avg. 98.89% | Avg: -$0.14 Low: -$0.24 High: -$0.05 avg. 32.78% | Avg: -$0.23 Low: -$0.29 High: -$0.19 avg. -68.28% | |
Operating Expenses
% change YoY
| $2.01B N/A | $2.48B 23.34% | $1.06B -57.22% | Avg: $391.93M Low: $306.43M High: $559.88M avg. -63.08% | Avg: $526.61M Low: $458.58M High: $629.11M avg. 34.36% | Avg: $961.69M Low: $837.46M High: $1.14B avg. 82.61% | |
FAQ
What is Ginkgo Bioworks Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 9.27% in 2025-2027.
We have gathered data from 4 analysts. Their low estimate is -583.32M, average is -431.02M and high is -291.66M.
What is Ginkgo Bioworks Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 38.39% in 2025-2027.
We have gathered data from 5 analysts. Their low revenue estimate is $193.06M, average is $246.92M and high is $352.74M.
What is Ginkgo Bioworks Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.12% in 2025-2027.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.3, average is -$0.2 and high is $-0.15.
What is the best performing analyst?
In the last twelve months analysts have been covering Ginkgo Bioworks Holdings stock. The most successful analyst is Ginkgo Bioworks whose win rate is 100%. He has correctly predicted 1/1 price targets.